Literature DB >> 9500854

Identification, quantitation, and cellular localization of PDE1 calmodulin-stimulated cyclic nucleotide phosphodiesterases.

W K Sonnenburg1, S D Rybalkin, K E Bornfeldt, K S Kwak, I G Rybalkina, J A Beavo.   

Abstract

The calmodulin-stimulated cyclic nucleotide phosphodiesterases (PDE1s) constitute a large gene family and are found in a wide variety of tissues and cells. Because of the functional diversity of PDE1 genes and the observation that these isozymes often make up a major component of the total cyclic nucleotide hydrolytic activity in certain cell types, PDE1s are of growing interest as targets for therapeutic intervention. Here we describe a series of methodologies to identify, quantitate, and determine the cellular expression of PDE1 isozymes. We describe first the resolution of different PDEs using high-performance anion-exchange chromatography and then a Western blotting methodology for identifying or authenticating PDE1 activities. Next we present an immunoprecipitation method that can be used for quantitating specific PDE1 isoforms and describe the use of RNase protection analysis for further identification of PDE1 subtypes. Finally, we provide a simple, immunocytochemical method for determining the cellular expression of PDE1 isozymes. Combined, the above methodologies should allow an investigator to identify, quantitate, and determine the cellular localization of PDE1 isozymes in any tissue with little ambiguity. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500854     DOI: 10.1006/meth.1997.0561

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  17 in total

1.  PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.

Authors:  Sergei D Rybalkin; Irina G Rybalkina; Masami Shimizu-Albergine; Xiao-Bo Tang; Joseph A Beavo
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

2.  PDE1B2 regulates cGMP and a subset of the phenotypic characteristics acquired upon macrophage differentiation from a monocyte.

Authors:  Andrew T Bender; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

3.  Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1.

Authors:  Fernanda R Giachini; Victor V Lima; Fernando S Carneiro; Rita C Tostes; R Clinton Webb
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

Review 4.  Imaging second messenger dynamics in developing neural circuits.

Authors:  Timothy A Dunn; Marla B Feller
Journal:  Dev Neurobiol       Date:  2008-05       Impact factor: 3.964

5.  Kaempferia parviflora, a plant used in traditional medicine to enhance sexual performance contains large amounts of low affinity PDE5 inhibitors.

Authors:  Prapapan Temkitthawon; Thomas R Hinds; Joseph A Beavo; Jarupa Viyoch; Khanit Suwanborirux; Wittaya Pongamornkul; Pattara Sawasdee; Kornkanok Ingkaninan
Journal:  J Ethnopharmacol       Date:  2011-08-30       Impact factor: 4.360

Review 6.  Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.

Authors:  Liliane Tetsi; Anne-Laure Charles; Stéphanie Paradis; Anne Lejay; Samy Talha; Bernard Geny; Claire Lugnier
Journal:  Cell Mol Life Sci       Date:  2016-12-30       Impact factor: 9.261

7.  Enzyme assays for cGMP hydrolyzing phosphodiesterases.

Authors:  Sergei D Rybalkin; Thomas R Hinds; Joseph A Beavo
Journal:  Methods Mol Biol       Date:  2013

8.  Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes.

Authors:  Manling Zhang; Norimichi Koitabashi; Takahiro Nagayama; Ryan Rambaran; Ning Feng; Eiki Takimoto; Trisha Koenke; Brian O'Rourke; Hunter C Champion; Michael T Crow; David A Kass
Journal:  Cell Signal       Date:  2008-08-26       Impact factor: 4.315

9.  Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.

Authors:  Clint L Miller; Masayoshi Oikawa; Yujun Cai; Andrew P Wojtovich; David J Nagel; Xiangbin Xu; Haodong Xu; Vince Florio; Sergei D Rybalkin; Joseph A Beavo; Yiu-Fai Chen; Jian-Dong Li; Burns C Blaxall; Jun-ichi Abe; Chen Yan
Journal:  Circ Res       Date:  2009-09-24       Impact factor: 17.367

Review 10.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.